Nicotine Ayrton Saunders (Nicotine)

Nicotine Ayrton Saunders is used within the smoking‑cessation pathway to address tobacco‑related dependence.

• Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms when quitting tobacco.
• Nicotine dependence: supports gradual reduction of nicotine intake in individuals seeking to stop smoking.
• Tobacco use disorder: assists in managing the physiological aspects of nicotine addiction.

• Nicotine acts as an agonist at neuronal nicotinic acetylcholine receptors, primarily the α4β2 subtype. Activation of these receptors stimulates dopamine release in the mesolimbic pathway, which mitigates withdrawal symptoms and reduces the reinforcing effects of tobacco smoking, thereby facilitating cessation efforts.

Adverse reactions may occur with inhaled nicotine products. Monitoring for both common and serious events is recommended.

Common Side Effects

• Cough: mild irritation of the respiratory tract.
• Throat irritation: transient soreness or dryness.
• Nausea: occasional upset stomach.
• Headache: mild to moderate intensity.
• Dizziness: brief episodes of light‑headedness.
• Increased salivation: temporary excess saliva.

Serious or Rare Side Effects

• Hypertension: elevated blood pressure requiring medical evaluation.
• Arrhythmia: irregular heart rhythm, potentially serious.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Respiratory distress: difficulty breathing or wheezing.
• Chest pain: may indicate cardiac involvement.
• Persistent vomiting: could lead to dehydration.

When prescribing inhaled nicotine, consider patient‑specific factors and safety measures.

• Cardiovascular disease: assess risk before initiating therapy.
• Pregnancy or lactation: avoid use unless benefits outweigh potential risks.
• Respiratory conditions: monitor patients with asthma or COPD closely.
• Concomitant stimulant use: evaluate for additive sympathomimetic effects.
• Age restriction: intended for adult use only; not recommended for minors.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nicotine may interact with other agents that affect cardiovascular or central nervous system function.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Beta‑blockers: may blunt nicotine‑induced tachycardia, complicating monitoring.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): possible additive stimulant effects.
• Antihypertensives: nicotine may reduce efficacy, requiring dose adjustment.
• Caffeine: combined stimulant effect may increase anxiety or insomnia.
• Alcohol: may enhance nicotine’s cardiovascular impact.
• Other nicotine replacement products: risk of nicotine over‑exposure.